Column Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,136,735
| Closed | -$28.8M | – | 7 |
|
|
2024
Q1 | $28.8M | Hold |
18,136,735
| – | – | 17.96% | 3 |
|
|
2023
Q4 | $15.6M | Hold |
18,136,735
| – | – | 10.29% | 4 |
|
|
2023
Q3 | $19.4M | Hold |
18,136,735
| – | – | 12.89% | 5 |
|
|
2023
Q2 | $47M | Hold |
18,136,735
| – | – | 18.23% | 4 |
|
|
2023
Q1 | $74M | Hold |
18,136,735
| – | – | 26.76% | 2 |
|
|
2022
Q4 | $91M | Hold |
18,136,735
| – | – | 30.31% | 2 |
|
|
2022
Q3 | $237M | Hold |
18,136,735
| – | – | 52.51% | 1 |
|
|
2022
Q2 | $233M | Buy |
18,136,735
+1,890,918
| +12% | +$24.2M | 49.49% | 1 |
|
|
2022
Q1 | $248M | Buy |
16,245,817
+849,701
| +6% | +$13M | 45.93% | 1 |
|
|
2021
Q4 | $273M | Hold |
15,396,116
| – | – | 37.08% | 1 |
|
|
2021
Q3 | $324M | Hold |
15,396,116
| – | – | 36.81% | 1 |
|
|
2021
Q2 | $304M | Hold |
15,396,116
| – | – | 42.97% | 1 |
|
|
2021
Q1 | $448M | Hold |
15,396,116
| – | – | 42.88% | 1 |
|
|
2020
Q4 | $467M | Buy |
+15,396,116
| New | +$467M | 42.31% | 1 |
|